ophthalmologyadvisor2d
Intraocular Lens Choice Update: Personalize Options While Optimizing Time
Intraocular lens choice, as facilitated by the surgeon, can connect the patient with the appropriate device for their ...
Ophthalmic Devices Market Is Expected To Reach Revenue Of USD 120.3 Bn By 2033, At 5.1% CAGR: Dimension Market Research.
Advancements and Projections in the Ophthalmic Devices Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...
Reasons to Retain Alcon Stock in Your Portfolio for Now
Surgical Business Grows: Alcon’s Surgical business continues to gain from the company’s diverse portfolio and incremental innovation. ALC’s flagship lenses, Vivity and PanOptix, continue to lead the ...
ophthalmologytimes18d
NIH-led studies signal potential development of a cataract drug
According to a team of researchers at the National Institutes of Health, their findings in animals suggest a surgery-free treatment for cataracts. Researchers at the National Institutes of Health (NIH ...
ophthalmologytimes19d
From waste to wonder: Transformational advances in scleral allograft technology
In data from a recent study presented at both the American Academy of Ophthalmology 2023 and American Society of Cataract and Refractive Surgery ... Herndon serves as a consultant to Alcon, ...
Business Insider22d
Buy Rating Affirmed: Alcon’s Growth Prospects Bolstered by Unity VCS and New Product Pipeline
Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive ...